GRI Bio, Inc. (NASDAQ:GRI) filed its annual report (Form 10-K) with the Securities and Exchange Commission on January 30, 2026.
The Healthcare company reported annual revenue of and net income of for fiscal year 0.
GRI Bio, Inc.'s stock currently trades at $3.26 with a market capitalization of $1.3M.
